The 20 Best Cutaneous Lupus Erythematosus (CLE) Doctors Near Me in Ann Arbor, MI

Dr. J. Michelle Kahlenberg MD, PhD is a physician scientist and Associate Professor of Internal Medicine at the University of Michigan. She completed her MD, PhD, and Internal Medicine training at Case Western Reserve University and completed her fellowship in Rheumatology at the University of Michigan. She joined the University of Michigan faculty in 2011, was appointed Assistant Professor in 2012, and was promoted to Associate Professor with tenure in 2018. She has been running her own laboratory and has been an active member of the Immunology Training Program since 2013. Her clinical work is centered on the care of complicated lupus patients, including those with refractory skin disease. Her R01-funded research laboratory combines translational approaches using patient samples and murine models to uncover the mechanisms that drive lupus and lupus flares. In particular, she is focused on unraveling the pathogenic mechanisms in cutaneous lupus, the factors that drive photosensitivity, and how skin inflammation can influence systemic lupus activity. Her work has received institutional accolades and national recognition from the Arthritis National Research Foundation, The Rheumatology Research Foundation, American Society for Clinical Investigation and the Lupus Foundation of America. In her spare time, she enjoys organic gardening, working on the family farm EMMA Acres run by her husband, Mark, and spending time with her husband and children. Dr. Kahlenberg is rated as an Elite provider by MediFind in the treatment of Cutaneous Lupus Erythematosus (CLE). She is also highly rated in 25 other conditions, according to our data. Her clinical expertise encompasses Cutaneous Lupus Erythematosus (CLE), Systemic Lupus Erythematosus (SLE), Discoid Lupus Erythematosus (DLE), and Mevalonate Kinase Deficiency. Dr. Kahlenberg is board certified in Rheumatology.

Johann Gudjonsson, MD, PhD is the Arthur C. Curtis Professor of Molecular Skin Immunology and the Frances and Kenneth Eisenberg Emerging Scholar of the Taubman Medical Research Institute. A graduate of the University of Iceland Medical School, he completed his internship and dermatology residency training at the University of Michigan. Dr. Gudjonsson has served on the faculty of the University of Michigan Department of Dermatology since 2008. He provides general medical dermatology patient care at the University of Michigan Taubman Center and maintains clinical and research interests in inflammatory and autoimmune disorders involving the skin.Dr. Gudjonsson came to the U-M in 2003 as part of an innovative research residency training program. Building upon investigative dermatology training completed in Iceland, Dr. Gudjonsson has been performing basic immunological and genetic work on psoriasis at the U-M. Dr. Gudjonsson's primary research focus is basic immunological and genetic research on psoriasis, with projects directed at improving the diagnosis and treatment of psoriasis. He received the 2007 Young Investigator Award from the American Academy of Dermatology, was named the 2018 Rising Star Lecturer for the Society for Investigative Dermatology and was recipient of the American Skin Association Research Achievement Award in Psoriasis in 2021. Dr. Gudjonsson's research has been supported by research awards from the National Institutes of Health (NIH), the American Skin Association, Dermatology Foundation, Doris Duke Foundation, among others. Dr. Gudjonsson is rated as an Elite provider by MediFind in the treatment of Cutaneous Lupus Erythematosus (CLE). He is also highly rated in 39 other conditions, according to our data. His clinical expertise encompasses Psoriasis, Darier Disease, Benign Chronic Pemphigus, Cutaneous Lupus Erythematosus (CLE), and Vitrectomy. Dr. Gudjonsson is board certified in Dermatology.

Dr. Allison Billi is an assistant professor in the University of Michigan Department of Dermatology. Her research aims to define how the skin contributes to systemic autoimmune disease through identifying female-biased pathways and factors in skin that are critical to autoimmunity. In addition, she provides medical dermatology care to patients of all ages within our outpatient clinic at Domino’s Farms.Dr. Billi is a graduate of the University of Michigan Medical School where she received her medical degree and her PhD in Human Genetics. Following graduation, she completed her transitional year at Beaumont Hospital in Dearborn, Michigan, and a dermatology residency and post-doctoral research fellowship at the University of Michigan Department of Dermatology. Dr. Billi is rated as a Distinguished provider by MediFind in the treatment of Cutaneous Lupus Erythematosus (CLE). She is also highly rated in 21 other conditions, according to our data. Her clinical expertise encompasses Cutaneous Lupus Erythematosus (CLE), Psoriasis, Lichen Planus, and Actinic Keratosis. Dr. Billi is board certified in Dermatology.

Wendy Marder is an Internal Medicine specialist and a Rheumatologist practicing medicine in Ann Arbor, Michigan. Dr. Marder is rated as a Distinguished provider by MediFind in the treatment of Cutaneous Lupus Erythematosus (CLE). She is also highly rated in 16 other conditions, according to our data. Her clinical expertise encompasses Systemic Lupus Erythematosus (SLE), Rheumatoid Arthritis (RA), Cutaneous Lupus Erythematosus (CLE), and Discoid Lupus Erythematosus (DLE).

Dr. Tejasvi received his medical degree from Karnataka Institute of Medical Sciences, India. He completed residency-training program and worked as senior resident in Dermatology and Venereology, from All India Institute of Medical Sciences, New Delhi, India. He completed post-doctoral training in genetics of psoriasis under the direction of Drs. R.P.Nair and James T. Elder at the University of Michigan, Department of Dermatology in Ann Arbor.Dr. Tejasvi's primary research interest is translational genetics, epigenetics in psoriasis and pharmacogenetics that involves application of genetic information to predict response to therapies. Dr. Tejasvi is rated as an Advanced provider by MediFind in the treatment of Cutaneous Lupus Erythematosus (CLE). He is also highly rated in 39 other conditions, according to our data. His clinical expertise encompasses Cutaneous T-Cell Lymphoma (CTCL), T-Cell Lymphoma, Mycosis Fungoides, and Lymphomatoid Papulosis.

Dr. Lowe received her undergraduate degree from Occidental College, Los Angeles, California in 1981 and her M.D. degree from the University of Texas Medical School at Houston, Houston, Texas in 1985. She did a transitional internship at St. Joseph's Hospital, Houston, Texas from 1985-1986 and then was a Post-doctoral Fellow in the Department of Dermatology at the University of Texas Medical School at Houston. From 1987-1989, she completed her residency training in dermatology at the University of Texas Medical School at Houston, followed by a Dermatopathology Fellowship at the University of Colorado School of Medicine, Denver, Colorado, from 1990-1991. Dr. Lowe is board certified in both Dermatology and Dermatopathology.In 1990, Dr. Lowe served as an Instructor in the Department of Dermatology at the University of Texas Medical School at Houston, Houston, Texas. She moved to the Department of Dermatology at Henry Ford Hospital, Detroit, Michigan, where she was a Senior Staff Physician and Director of Dermatopathology from 1991-1996. In 1996 she joined the faculty of the Departments of Pathology and Dermatology at the University of Michigan Medical School, Ann Arbor, Michigan, as Assistant Professor, where she was promoted to Associate Professor in 1998, and to Professor in 2004. She served as the Director of Dermatopathology in the Department of Pathology from 1996-2012.While at the University of Michigan Medical School, Dr. Lowe has been actively involved in the dermatopathology service, teaching and academic pursuits. She has been recognized institutionally and nationally as an educator and clinician. In 2013, Dr. Lowe received the Walter Nickel Teaching Award given by the American Society of Dermatopathology and also received the Outstanding Clinician of the Year Award bestowed by the University of Michigan Medical School. In 2015, she was inducted into the University of Michigan League of Clinical Excellence. Dr. Lowe received the William B. Taylor Resident Teaching Award from the Department of Dermatology, University of Michigan in 1999 and 2005 for exemplary teaching. She has been recognized annually since 2003 in America's Top Doctors for Cancer by Castle Connolly Medical Ltd. She has served on national committees, including the American Board of Dermatology, Dermatopathology Test Committee and the American Board of Pathology, Dermatopathology Test Committee and has served on the editorial boards of both the Journal of the American Academy of Dermatology and Cancer. Dr. Lowe is the author or co-author of more than 130 publications in peer-reviewed journals. Dr. Lowe is rated as an Advanced provider by MediFind in the treatment of Cutaneous Lupus Erythematosus (CLE). She is also highly rated in 21 other conditions, according to our data. Her clinical expertise encompasses Melanoma, Sebaceous Adenoma, Syringoma, and Syringocystadenoma Papilliferum. Dr. Lowe is board certified in Dermatology and Dermatopathology.

In 2008, Dr. Dlugosz was named Poth Professor of Cutaneous Oncology in the Dermatology Department at the University of Michigan in Ann Arbor. He is Scientific Director of the Cutaneous Oncology Program of the University of Michigan Comprehensive Cancer Center. He received his M.D. at the Pennsylvania State University College of Medicine in 1984, did an internship at the Roger Williams General Hospital in Providence, RI, and completed his dermatology residency, including a year as Chief Resident, at the University of Pennsylvania in Philadelphia, in 1988. He received his post-doctoral training with Dr. Stuart Yuspa at the National Cancer Institute, where he subsequently established an independent research program prior to his recruitment to the University of Michigan in 1997.Dr. Dlugosz has received multiple awards, grants, and fellowships from the National Institutes of Health, American Cancer Society, American Association for Cancer Research, Society for Investigative Dermatology, and Dermatology Foundation. He was elected to the American Society for Clinical Investigation in 2002, has been included in the Best Doctors in America listing since 2003, and was elected to the American Dermatological Association in 2005.The National Institutes of Health and other scientific agencies frequently enlist Dr. Dlugosz as a grant reviewer. He is also an ad hoc reviewer for multiple scholarly journals, and is frequently invited to speak, or chair sessions, at major scientific meetings both in the United States and abroad. Dr. Dlugosz is an author on over 60 published papers.Dr. Dlugosz's basic research program is centered on two interrelated areas. He is investigating how the abnormal regulation of an embryonic signaling pathway, called the Hedgehog pathway, causes tumor development in skin and several other organs. In other studies, he is investigating the role of the Hedgehog pathway in development, growth, and regeneration of hair follicles and related structures. Dr. Dlugosz is rated as an Experienced provider by MediFind in the treatment of Cutaneous Lupus Erythematosus (CLE). He is also highly rated in 88 other conditions, according to our data. His clinical expertise encompasses Cicatricial Pemphigoid, Pemphigus, Bullous Pemphigoid, and Pemphigus Vulgaris. Dr. Dlugosz is board certified in Dermatology.

Dr. Maya Aravind is a board-certified dermatologist and Assistant Professor of Dermatology at the University of Michigan. She provides medical dermatology diagnosis and treatment to patients of all ages within in our medical dermatology outpatient clinics.Dr. Aravind received her medical degree from the University of Michigan Medical School, and her master of science degree in clinical research from the University of Michigan School of Public Health Rackham School of Graduate Studies. Following graduation, she completed her transitional year internship at Oakwood Hospital in Dearborn, MI, and her dermatology residency at the U-M Department of Dermatology. Dr. Aravind practiced dermatology in Tennessee and Texas before joining the clinical faculty of the University of Michigan Department of Dermatology in 2022. Dr. Aravind is rated as an Experienced provider by MediFind in the treatment of Cutaneous Lupus Erythematosus (CLE). She is also highly rated in 38 other conditions, according to our data. Her clinical expertise encompasses Actinic Keratosis, Melanoma, Warts, and Seborrheic Keratosis.

Dr. Grace Osborne is Clinical Assistant Professor in the Departments of Dermatology and Pediatrics and is a board-certified dermatologist and a fellowship-trained pediatric dermatologist. She provides dermatological diagnosis and treatment to patients of all ages in our medical dermatology and pediatric dermatology outpatient clinics.Dr. Osborne received her medical degree from Southern Illinois University School of Medicine, then completed her transitional year internship at St. Mary Mercy Hospital in Livonia. She completed her dermatology residency and pediatric dermatology fellowship at the University of Michigan Medical School. During her residency, Dr. Osborne pursued a postdoctoral research fellowship within our NIH funded T32 training program in the laboratory of Dr. J. Michelle Kahlenberg. Dr. Osborne joined the Michigan Medicine Dermatology faculty in 2023. Dr. Osborne is rated as an Experienced provider by MediFind in the treatment of Cutaneous Lupus Erythematosus (CLE). She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Comedones, Melanoma, Urticaria Pigmentosa, and Molluscum Contagiosum. Dr. Osborne is board certified in Dermatology.

April Marquardt is an Internal Medicine specialist and a Rheumatologist practicing medicine in Ann Arbor, Michigan. Dr. Marquardt is rated as an Advanced provider by MediFind in the treatment of Cutaneous Lupus Erythematosus (CLE). She is also highly rated in 14 other conditions, according to our data. Her clinical expertise encompasses Neuroretinitis, Punctate Inner Choroidopathy, Scleritis, and Eales Disease. Dr. Marquardt is board certified in Rheumatology.

James Elder is a Dermatologist practicing medicine in Ann Arbor, Michigan. Dr. Elder is rated as an Experienced provider by MediFind in the treatment of Cutaneous Lupus Erythematosus (CLE). He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Psoriasis, Pityriasis Rubra Pilaris, Atopic Dermatitis, and Cutaneous Lupus Erythematosus (CLE).

Hiroshi Kato is an Internal Medicine specialist and a Rheumatologist practicing medicine in Ann Arbor, Michigan. Dr. Kato is rated as an Advanced provider by MediFind in the treatment of Cutaneous Lupus Erythematosus (CLE). He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Cutaneous Lupus Erythematosus (CLE), Lupus Nephritis, Necrotizing Vasculitis, and Rheumatoid Arthritis (RA). Dr. Kato is board certified in Internal Medicine and Rheumatology.

Dr. May Chan obtained her medical degree from the State University of New York at Buffalo and was a Howard Hughes Research Scholar in 2005-2006. She completed residency training in Anatomic Pathology at Beth Israel Deaconess Medical Center in Boston, followed by a Dermatopathology fellowship at Harvard. She joined the University of Michigan in 2011 and is now a Professor of Pathology and Dermatology. She is the Interim Section Head for Dermatopathology, the Program Director for the Dermatopathology Fellowship, and the Medical Director of the Immunohistochemistry Laboratory. She also serves on the Test Development and Advisory Committee of the American Board of Pathology.Dr. Chan is an editorial board member of Modern Pathology and Journal of Cutaneous Pathology. She has a broad research interest in the areas of inflammatory skin diseases, melanocytic lesions, cutaneous adnexal neoplasms, and immunohistochemistry. She is the author/co-author of over 90 peer-reviewed publications and the book, Handbook of Direct Immunofluorescence: A Pattern-based Approach to Skin and Mucosal Biopsies.Dr. Chan is board certified in Anatomic Pathology and Dermatopathology. In addition to her primary role as a dermatopathologist, Dr. Chan retains her interest in surgical pathology including interpretation of head and neck, soft tissue, pulmonary, and endocrine cases, as well as intraoperative frozen sections. Over the years she has been invited to speak at national and international meetings hosted by the United States and Canadian Academy of Pathology (USCAP), the American Society of Dermatopathology (ASDP), the College of American Pathologists (CAP), the American Society for Clinical Pathology (ASCP), the American Academy of Dermatology (AAD), the European Nail Society, and Dermpedia. Dr. Chan is rated as an Advanced provider by MediFind in the treatment of Cutaneous Lupus Erythematosus (CLE). She is also highly rated in 27 other conditions, according to our data. Her clinical expertise encompasses Melanoma, Basal Cell Skin Cancer, Sebaceous Adenoma, and Squamous Cell Skin Carcinoma.

Dr. Fox is a graduate of the Massachusetts Institute of Technology and Harvard Medical School. Following internal medicine residency and rheumatology fellowship at the Brigham and Women's Hospital, he joined the faculty of the University of Michigan School of Medicine in 1985. Dr. Fox is Professor of Internal Medicine and, from 1990 to 2018, was Chief of the Division of Rheumatology. In addition, he co-directs the University of Michigan Clinical Autoimmunity Center of Excellence. In 2013, Dr. Fox became the Frederick G. L. Huetwell and William D. Robinson, M.D. Professor of Rheumatology. Dr. Foxs research focuses on defining and characterizing pathways of human T cell activation, determining the role of these pathways in the pathogenesis of autoimmune disease, investigating T cell interactions with synovial fibroblasts, understanding the role of interleukin-17 in arthritis, and exploring novel approaches to the treatment of rheumatoid arthritis and scleroderma. He is author of more than 230 scientific papers and book chapters and has served on the Editorial Board of Arthritis & Rheumatism, as an Associate Editor and Section Editor of the Journal of Immunology and as an Associate Editor of the Journal of Clinical Investigation. His published work has been cited more than 10,000 times. He is a member of the American Society for Clinical Investigation and the Association of American Physicians. Dr. Fox is also active in the clinical care of patients with rheumatic diseases and in teaching students and fellows in both clinical and research settings. Dr. Fox has been an ACR ()American College of Rheumatology) member since 1985, an ACR volunteer since 1991, and an ACR Master since 2018. He has been a member of 12 ACR and RRF committees and task forces and chaired the Publications Committee, Finance Committee, and Monitoring Committee. In 2011-2012, Dr. Fox later co-chaired the ACR Task Force on Academic Rheumatology. From 2007-2008, Dr. Fox served as the seventy-first President of the American College of Rheumatology and the sixth ACR President from the University of Michigan. Dr. Fox currently holds leadership positions in the Immune Tolerance Network and in the Biomarkers Consortium of the Foundation for the NIH. Dr. Fox is rated as an Advanced provider by MediFind in the treatment of Cutaneous Lupus Erythematosus (CLE). He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Rheumatoid Arthritis (RA), Adult Still's Disease, Necrotizing Vasculitis, Scleroderma, and Tissue Biopsy.

After receiving my M.D. and Ph.D. at the University of Alabama at Birmingham, I came to the University of Michigan for residency training in Anatomic Pathology. During my residency and subsequent Dermatopathology fellowship, I became interested in mechanistic studies of cutaneous and soft-tissue malignancies. Upon completion of my fellowship in June 2012, I accepted a faculty position at UMHS with joint appointments in the Departments of Dermatology and Pathology, in which I continue to investigate molecular events in the pathogenesis of Merkel cell carcinoma and other cutaneous malignancies, while maintaining clinical effort in dermatopathology and molecular dermatopathology. Dr. Harms is rated as an Advanced provider by MediFind in the treatment of Cutaneous Lupus Erythematosus (CLE). He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Merkel Cell Carcinoma, Tieche-Jadassohn Nevus, Melanoma, and Sebaceous Adenoma. Dr. Harms is board certified in Pathology-Anatomic and Dermatopathology.

William Mccune is an Internal Medicine specialist and a Rheumatologist practicing medicine in Ann Arbor, Michigan. Dr. Mccune is rated as an Advanced provider by MediFind in the treatment of Cutaneous Lupus Erythematosus (CLE). He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Granulomatosis with Polyangiitis, Systemic Lupus Erythematosus (SLE), Lupus Nephritis, Vasculitis, and Splenectomy. Dr. Mccune is board certified in Internal Medicine and Rheumatology.

John Voorhees is a Dermatologist practicing medicine in Ann Arbor, Michigan. Dr. Voorhees is rated as an Experienced provider by MediFind in the treatment of Cutaneous Lupus Erythematosus (CLE). He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Psoriasis, Cutaneous Lupus Erythematosus (CLE), Actinic Keratosis, and Localized Scleroderma.

Dr. Frank Wang, MD is a board-certified Dermatologist. He graduated from Stanford University and received his medical degree from Cornell University Medical College. Dr. Wang served his internship at the University of Pittsburgh Medical Center, and went on to complete a Fellowship and his Dermatology Residency here at the University of Michigan. In 2010, Dr. Wang joined the faculty at the University of Michigan Department of Dermatology. His interests and expertise include general clinical dermatology, and clinical and basic science research in the area of skin aging. Dr. Wang is rated as an Advanced provider by MediFind in the treatment of Cutaneous Lupus Erythematosus (CLE). He is also highly rated in 57 other conditions, according to our data. His clinical expertise encompasses Psoriasis, Actinic Keratosis, Pyoderma Gangrenosum, and Melanoma. Dr. Wang is board certified in Dermatology.

Dr. Yolanda Helfrich is a clinical professor of dermatology and the residency program director of the Department of Dermatology at the University of Michigan Medical School.Dr. Helfrich’s primary clinical focus is on medical dermatology. She has a special interest in rosacea, and has been invited to speak and write nationally about the pathogenesis and treatment of rosacea. She serves on the National Rosacea Society Medical Advisory Board. She also has a clinical specialization in the follow-up and diagnosis of high-risk skin cancer patients and runs a specialty clinic devoted to the care of patients with alopecia (hair loss).Throughout her career, Dr. Helfrich has had a strong interest in clinical research, and served as the Director of the Program for Clinical Research in Dermatology (PCRiD) in the department for 12 years. She has served as Primary Investigator on over 25 departmental and industry-sponsored clinical trials and research investigations of rosacea, atopic dermatitis, psoriasis, lichen planus, and other dermatologic conditions. She served on the Michigan Medicine Research Board of Directors Clinical Trials Subcommittee, with the key task of helping the institution create a unified clinical research enterprise, and subsequently served as one of the inaugural Medical Directors of the Neurosciences and Sensory Clinical Trials Support Unit. Dr. Helfrich embraces her role as an educator, and has served as the Residency Program Director in Dermatology since January 2016. She has worked hard to optimize the clinical training and educational environment for residents within the program. She was recently elected to the American Professors of Dermatology Program Directors Steering Committee. She also serves on the Michigan Medicine Graduate Medical Education Committee (GMEC). In 2015, she was elected to Michigan Medicine’s League of Educational Excellence, which honors instructional faculty for their extraordinary contributions to teaching and inspiring the next generation of Michigan physicians and scientists.Dr. Helfrich is a Michigan native. She grew up in Grayling and attended Grayling High School. She graduated with a B.A. in Latin and Ancient History from Swarthmore College in Pennsylvania. She subsequently attended medical school at the University of Michigan Medical School, graduating in 2001. Dr. Helfrich completed her internship in internal medicine and her residency in dermatology at the University of Michigan. She joined the faculty at the University of Michigan Department of Dermatology in 2. Dr. Helfrich is rated as an Advanced provider by MediFind in the treatment of Cutaneous Lupus Erythematosus (CLE). She is also highly rated in 52 other conditions, according to our data. Her clinical expertise encompasses Actinic Keratosis, Rosacea, Graham-Little-Piccardi-Lassueur Syndrome, and Melanoma. Dr. Helfrich is board certified in Dermatology.

Elizabeth Spratt is a Dermatologist practicing medicine in Ann Arbor, Michigan. Dr. Spratt is rated as an Experienced provider by MediFind in the treatment of Cutaneous Lupus Erythematosus (CLE). She is also highly rated in 31 other conditions, according to our data. Her clinical expertise encompasses Actinic Keratosis, Melanoma, Giant Congenital Melanocytic Nevus, and Giant Congenital Nevus.